Conduit Pharmaceuticals Inc. (CDT) — Net Asset Quality Index
Conduit Pharmaceuticals Inc. (CDT) has a Net Asset Quality Index of 37.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.46 Billion minus total liabilities of $2.18 Billion yields net assets of $1.28 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Conduit Pharmaceuticals Inc. (CDT) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Conduit Pharmaceuticals Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how Conduit Pharmaceuticals Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 37.1%, representing net assets of $1.28 Billion against total assets of $3.46 Billion USD. See working capital position of Conduit Pharmaceuticals Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Conduit Pharmaceuticals Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Conduit Pharmaceuticals Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Conduit Pharmaceuticals Inc. stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.7% | $1.26 Billion | $3.54 Billion | $2.28 Billion | ▲ +197.7 pp |
| 2024 | -162.0% | $-6.79 Million | $4.19 Million | $10.99 Million | ▼ -155.7 pp |
| 2023 | -6.3% | $-457.00K | $7.22 Million | $7.68 Million | ▲ +201773.7 pp |
| 2022 | -201780.0% | $-10.09 Million | $5.00K | $10.09 Million | ▼ -201789.7 pp |
| 2021 | 9.7% | $20.62K | $213.12K | $192.51K | — |